-
Nucleic Acid Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund
-
designing, synthesising, and evaluating existing and new chemical modifications for nucleic acid therapeutics. In addition, the Research Scientist will design and implement processes and workflows for nucleic
Searches related to Design
Enter an email to receive alerts for Design positions in CHEMISTRY